Chiasmal glioma in neurofibromatosis type 1 with severe visual loss regained with radiation

C Adams1, W A Fletcher, S T Myles

  • 1Department of Pediatric Neurology, Alberta Childrens Hospital, University of Calgary, Canada.

Pediatric Neurology
|July 1, 1997
PubMed

Insights

Children with neurofibromatosis type 1 (NF1) and chiasmal gliomas may experience vision loss. This case report details a child with NF1 and chiasmal glioma who regained significant vision after radiotherapy.

Area of Science:

  • Pediatric Oncology
  • Neuro-oncology
  • Ophthalmology

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder associated with increased risk of optic pathway gliomas.
  • Chiasmal gliomas in children with NF1 are often monitored without immediate intervention due to perceived low risk of progression.
  • The management of chiasmal gliomas remains a topic of debate, particularly regarding the role of radiotherapy.

Observation:

  • A 5-year-old boy with a recent NF1 diagnosis developed a chiasmal glioma.
  • The child experienced rapid deterioration of visual acuity following the glioma diagnosis.
  • Neuroimaging confirmed the presence of a chiasmal glioma.

Findings:

  • Despite the common assumption of slow progression, this case demonstrates rapid visual loss in a pediatric chiasmal glioma.
  • The patient's vision significantly improved following radiation therapy.
  • This outcome challenges the conservative management approach in select cases.

Implications:

  • Radiotherapy may be a viable and effective treatment option for pediatric chiasmal gliomas presenting with rapid visual decline.
  • Further research is warranted to clarify the indications and long-term efficacy of radiotherapy for NF1-associated chiasmal gliomas.
  • This case highlights the importance of vigilant monitoring and individualized treatment strategies for children with NF1 and optic pathway tumors.

Related Concept Videos